A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.
暂无分享,去创建一个
A. D'Amico | B. Mahal | P. Orio | P. Devlin | K. Mouw | V. Muralidhar | M. King | David D. Yang | P. Nguyen | L. Lee | S. Butler | Neil M Martin